AVILEX PHARMA ApS — CVR 34896828
Is this your company?
Verify ownership and add your website, description, services, products, logo, socials and more.
Claim & enrichReviews
Loading…
Verified reviews from Søge users
Company relationship network
Building the network…
Node colour = company status · blue dot = person. Edge colour = how they are linked: ownership, management, founder, or a shared phone / e-mail / website. Toggle any relation type off with the filters. Double-click a company to open it.
Active
Founded 2012
4 employees
CVR
34896828
↗ Datacvr
Status
Active
Company form
Private limited (ApS)
Start date
2012-12-27
Addresses
Jagtvej 162, 2100 København Ø
(KØBENHAVN)
Employees
4
Employment interval
ANTAL_2_4
Advertising protected
Yes
Industry (3)
Uoplyst
999999
Forskning og eksperimentel udvikling indenfor bioteknologi
721100
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
721000
Website (1)
http://www.avilexpharma.com
2021-04-13
Addresses (4)
Ole Maaløes Vej 3,
2200 København N
(KØBENHAVN)
2012-12-27
Jagtvej 162,
2100 København Ø
(KØBENHAVN)
2014-09-03
Ole Maaløes Vej 3,
2200 København N
(KØBENHAVN)
2015-03-03
Jagtvej 162,
2100 København Ø
(KØBENHAVN)
2026-08-03
Relations (22)
Bobby G Soni
Chairman
Profile
Ingelise Saunders
Chairman
Profile
Camilla Petrycer Hansen
Board member
Profile
Mikael Søndergaard Thomsen
Legal owner
Profile
Ownership: 5%
· Voting: 5%
Kristian Strømgaard
Board memberADM. DIR.Legal owner
Profile
Ownership: 10%
· Voting: 10%
Anders Bach
FoundersBoard member
Profile
Henrijette Elsebeth Richter
Chairman
Profile
Nanna Liebach Lüneborg
Director
Profile
Emmanuelle Coutanceau
Board member
Profile
Morten Døssing
Board member
Profile
R.G. HOLDING A/S
Auditor
Profile
JUT NR. 2180 A/S
Auditor
Profile
KR 483 A/S
Auditor
Profile
MIKAEL SØNDERGÅRD THOMSEN ApS
Legal owner
Profile
Ownership: 5%
· Voting: 5%
KRISTIAN STRØMGAARD HOLDING ApS
Legal owner
Profile
Ownership: 10%
· Voting: 10%
Anders Bach IVS
Legal owner
Profile
Ownership: 10%
· Voting: 10%
Robert Giles Tansley
ADM. DIR.
Profile
Raymond George Hill
Board member
Profile
Jonathan Mark Treherne
Board memberADM. DIR.
Profile
Lifecycle (1)
2012-12-27 — now
Employees per month
| Period | Employees | FTE (man-years) |
|---|---|---|
| 2025-12 | 4 | 1.84 |
| 2025-11 | 4 | 1.81 |
| 2025-10 | 4 | 1.71 |
| 2025-09 | 4 | 1.73 |
| 2025-08 | 4 | 1.78 |
| 2025-07 | 4 | 1.71 |
| 2025-06 | 4 | 1.84 |
| 2025-05 | 4 | 1.81 |
| 2025-04 | 4 | 1.84 |
| 2025-03 | 4 | 1.76 |
| 2025-02 | 4 | 1.81 |
| 2025-01 | 4 | 1.73 |
| 2024-12 | 4 | 1.88 |
| 2024-11 | 4 | 1.76 |
| 2024-10 | 4 | 1.71 |
| 2024-09 | 4 | 1.76 |
| 2024-08 | 4 | 1.73 |
| 2024-07 | 4 | 1.69 |
| 2024-06 | 4 | 1.84 |
| 2024-05 | 4 | 1.76 |
| 2024-04 | 4 | 1.81 |
| 2024-03 | 4 | 1.84 |
| 2024-02 | 4 | 1.76 |
| 2024-01 | 4 | 1.73 |
| 2023-12 | 4 | 1.84 |
| 2023-11 | 4 | 1.73 |
| 2023-10 | 4 | 1.73 |
| 2023-09 | 4 | 1.76 |
| 2023-08 | 4 | 1.69 |
| 2023-07 | 4 | 1.76 |
| 2023-06 | 4 | 1.76 |
| 2023-05 | 4 | 1.81 |
| 2023-04 | 4 | 1.94 |
| 2023-03 | 4 | 1.69 |
| 2023-02 | 4 | 1.81 |
| 2023-01 | 4 | 1.73 |
| 2022-12 | 4 | 1.76 |
| 2022-11 | 4 | 1.73 |
| 2022-10 | 4 | 1.76 |
| 2022-09 | 5 | 1.82 |
| 2022-08 | 5 | 1.74 |
| 2022-07 | 5 | 3 |
| 2022-06 | 4 | 1.76 |
| 2022-05 | 4 | 1.81 |
| 2022-04 | 5 | 3 |
| 2022-03 | 4 | 1.69 |
| 2022-02 | 4 | 1.81 |
| 2022-01 | 5 | 1.8 |
| 2021-12 | 4 | 1.74 |
| 2021-11 | 4 | 1.71 |
| 2021-10 | 4 | 1.76 |
| 2021-09 | 4 | 3 |
| 2021-08 | 2 | 0.16 |
| 2021-07 | 4 | 1.71 |
| 2021-06 | 4 | 1.71 |
| 2021-05 | 4 | 1.84 |
| 2021-04 | 5 | 2 |
| 2021-03 | 4 | 1.69 |
| 2021-02 | 4 | 1.79 |
| 2021-01 | 4 | 1.79 |
| 2020-12 | 4 | 1.79 |
| 2020-11 | 5 | 1.83 |
| 2020-10 | 4 | 1.73 |
| 2020-09 | 4 | 1.73 |
| 2020-08 | 4 | 1.76 |
| 2020-07 | 5 | 1.8 |
| 2020-06 | 4 | 1.79 |
| 2020-05 | 4 | 1.84 |
| 2020-04 | 4 | 1.82 |
| 2020-03 | 5 | 1.78 |
| 2020-02 | 4 | 1.81 |
| 2020-01 | 5 | 1.81 |
| 2019-12 | 4 | 1.88 |
| 2019-11 | 4 | 1.74 |
| 2019-10 | 4 | 1.69 |
Production units (1)
Registration history
2026-08-03
Addresses
2015-03-03
Addresses
2014-09-03
Addresses
2012-12-27
Addresses
2012-12-27
Name history: AVILEX PHARMA ApS
2012-12-27
Company registered
Attributes
ARKIV_REGISTRERINGSNUMMER
ApS523044
Purpose
Selskabets formål er udvikling af behandlingsmæssige peptider eller afledte peptider (monomer, dimer og trimer) eller små molekylære forbindelser som er rettet mod PDZ domæner og relateret virksomhed besluttet af bestyrelsen.
First financial period end
2013-12-31
First financial period start
2012-12-27
Registered capital
80,000 DKK; 283,686 DKK; 408,686 DKK; 469,198 DKK
Share classes
Yes; Yes; Yes
Capital currency
DKK
Pseudo CVR number
No
Financial year end
31.12
Financial year start
01.01
Audit opted out
No
Signing rule
Selskabet tegnes af en direktør i forening med bestyrelsesformanden, eller af to bestyrelsesmedlemmer i forening, eller af bestyrelsesformanden i for-ening med et andet bestyrel-sesmedlem.; Selskabet tegnes af en direktør i forening med bestyrelsesformanden, eller af to bestyrelsesmedlemmer i forening, eller af bestyrelsesformanden i forening med et andet bestyrelsesmedlem.
Latest articles date
2012-12-27; 2015-04-30; 2018-12-21; 2019-09-20; 2020-04-30; 2020-10-19; 2021-08-31; 2022-09-23
Similar companies
Searching...
Didn't find what you need? Try searching
Vehicles